148 related articles for article (PubMed ID: 26591668)
1. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia.
Jima YT; Angamo MT; Wabe NT
Tanzan J Health Res; 2013 Jan; 15(1):11-8. PubMed ID: 26591668
[TBL] [Abstract][Full Text] [Related]
2. Multi-state Markov model for time to treatment changes for HIV/AIDS patients: a retrospective cohort national datasets, Ethiopia.
Kumsa TH; Mulu A; Beyene J; Asfaw ZG
BMC Infect Dis; 2024 Jun; 24(1):627. PubMed ID: 38914968
[TBL] [Abstract][Full Text] [Related]
3. The Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.
Woldemedhin B; Wabe NT
N Am J Med Sci; 2012 Jan; 4(1):19-23. PubMed ID: 22393543
[TBL] [Abstract][Full Text] [Related]
4. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
Birlie B; Braekers R; Awoke T; Kasim A; Shkedy Z
BMC Infect Dis; 2017 Jun; 17(1):453. PubMed ID: 28655306
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Adverse Drug Reactions among Pediatric Patients on Antiretroviral Therapy in Selected Hospitals in Eastern Ethiopia: 8-Year Retrospective Cross-Sectional Study.
Abdela J; Assefa A; Shamele S
J Int Assoc Provid AIDS Care; 2019; 18():2325958218823208. PubMed ID: 30798673
[TBL] [Abstract][Full Text] [Related]
7. Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.
Bokore A; Korme B; Bayisa G
BMC Pharmacol Toxicol; 2018 Jun; 19(1):28. PubMed ID: 29871665
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
[TBL] [Abstract][Full Text] [Related]
9. Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.
Sun J; Liu L; Shen J; Qi T; Wang Z; Song W; Zhang R; Lu H
PLoS One; 2015; 10(7):e0133242. PubMed ID: 26207639
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
11. Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study.
Ayele T; Jarso H; Mamo G
AIDS Res Ther; 2017 Feb; 14(1):5. PubMed ID: 28143541
[TBL] [Abstract][Full Text] [Related]
12. Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.
Gleason RL; Caulk AW; Seifu D; Rosebush JC; Shapiro AM; Schwartz MH; Eckard AR; Amogne W; Abebe W
J Biomech; 2016 Sep; 49(13):2584-2592. PubMed ID: 27270208
[TBL] [Abstract][Full Text] [Related]
13. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
Namme Luma H; Doualla MS; Choukem SP; Temfack E; Ashuntantang G; Achu Joko H; Koulla-Shiro S
Pan Afr Med J; 2012; 12():87. PubMed ID: 23077708
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
Tadios Y; Davey G
Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
Humphreys EH; Hernandez LB; Rutherford GW
Cochrane Database Syst Rev; 2007 Oct; (4):CD006517. PubMed ID: 17943914
[TBL] [Abstract][Full Text] [Related]
19. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
